Literature DB >> 22579752

Targeted proteome investigation via selected reaction monitoring mass spectrometry.

Alessio Maiolica1, Martin A Jünger, Iakes Ezkurdia, Ruedi Aebersold.   

Abstract

Due to the enormous complexity of proteomes which constitute the entirety of protein species expressed by a certain cell or tissue, proteome-wide studies performed in discovery mode are still limited in their ability to reproducibly identify and quantify all proteins present in complex biological samples. Therefore, the targeted analysis of informative subsets of the proteome has been beneficial to generate reproducible data sets across multiple samples. Here we review the repertoire of antibody- and mass spectrometry (MS) -based analytical tools which is currently available for the directed analysis of predefined sets of proteins. The topics of emphasis for this review are Selected Reaction Monitoring (SRM) mass spectrometry, emerging tools to control error rates in targeted proteomic experiments, and some representative examples of applications. The ability to cost- and time-efficiently generate specific and quantitative assays for large numbers of proteins and posttranslational modifications has the potential to greatly expand the range of targeted proteomic coverage in biological studies. This article is part of a Special Section entitled: Understanding genome regulation and genetic diversity by mass spectrometry.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579752     DOI: 10.1016/j.jprot.2012.04.048

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  24 in total

Review 1.  Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics.

Authors:  Bhagwat Prasad; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-04-22       Impact factor: 4.009

Review 2.  Quantifying ubiquitin signaling.

Authors:  Alban Ordureau; Christian Münch; J Wade Harper
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

Review 3.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

Review 4.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

Review 5.  Systems Proteomics View of the Endogenous Human Claudin Protein Family.

Authors:  Fei Liu; Michael Koval; Shoba Ranganathan; Susan Fanayan; William S Hancock; Emma K Lundberg; Ronald C Beavis; Lydie Lane; Paula Duek; Leon McQuade; Neil L Kelleher; Mark S Baker
Journal:  J Proteome Res       Date:  2016-01-12       Impact factor: 4.466

6.  Triple-Stage Mass Spectrometry Unravels the Heterogeneity of an Endogenous Protein Complex.

Authors:  Gili Ben-Nissan; Mikhail E Belov; David Morgenstern; Yishai Levin; Orly Dym; Galina Arkind; Carni Lipson; Alexander A Makarov; Michal Sharon
Journal:  Anal Chem       Date:  2017-04-06       Impact factor: 6.986

7.  Beyond the Western front: targeted proteomics and organelle abundance profiling.

Authors:  Harriet T Parsons; Joshua L Heazlewood
Journal:  Front Plant Sci       Date:  2015-05-05       Impact factor: 5.753

8.  Development of the schedule for multiple parallel "difficult" Peptide synthesis on pins.

Authors:  Ekaterina F Kolesanova; Maxim A Sanzhakov; Oleg N Kharybin
Journal:  Int J Pept       Date:  2013-08-20

Review 9.  Exposing the subunit diversity and modularity of protein complexes by structural mass spectrometry approaches.

Authors:  Dror S Chorev; Gili Ben-Nissan; Michal Sharon
Journal:  Proteomics       Date:  2015-04-29       Impact factor: 3.984

10.  Chloroquine interference with hemoglobin endocytic trafficking suppresses adaptive heme and iron homeostasis in macrophages: the paradox of an antimalarial agent.

Authors:  Christian A Schaer; Endre Laczko; Gabriele Schoedon; Dominik J Schaer; Florence Vallelian
Journal:  Oxid Med Cell Longev       Date:  2013-06-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.